POLXF — Polydex Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $6.82m
- $6.03m
- $4.86m
Annual cashflow statement for Polydex Pharmaceuticals, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2017 January 31st | 2018 January 31st | 2019 January 31st | 2020 January 31st | 2021 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.669 | 0.448 | 0.231 | 0.251 | 0.212 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0 | -0.002 | 0.026 | — | 0 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.542 | -0.43 | 0.265 | -0.329 | 0.762 |
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 0.528 | 0.288 | 0.734 | 0.195 | 1.26 |
| Capital Expenditures | -0.295 | -0.375 | -0.34 | -0.358 | -0.286 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.54 | -0.015 | 0.616 | -0.996 | -0.056 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.835 | -0.39 | 0.276 | -1.35 | -0.341 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.091 | 0.088 | -0.088 | -0.101 | -0.122 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.289 | -0.021 | 0.961 | -1.22 | 0.944 |